60 related articles for article (PubMed ID: 1720675)
1. [Nutritional support in non-Hodgkin's lymphoma treated with polychemotherapy MACOP-B cycle].
Boggio Bertinet D; Pezzana A; Vitolo U; Bertini M; Xompero G; Palmo A; Balzola F
Minerva Gastroenterol Dietol; 1991; 37(2):117-21. PubMed ID: 1720675
[TBL] [Abstract][Full Text] [Related]
2. [NEO-MACOP-B chemotherapy for the treatment of advanced-stage aggressive non-Hodgkin's lymphoma].
Kohda K; Tsuji A; Takayanagi N; Takeda M; Hayashi S; Takimoto R; Fujisaki Y; Tsuji Y; Ezoe A; Nakazawa O
Gan To Kagaku Ryoho; 1993 Nov; 20(14):2183-9. PubMed ID: 7694548
[TBL] [Abstract][Full Text] [Related]
3. Autologous stem cell transplantation in first-line treatment of high-risk aggressive non-Hodgkin's lymphoma.
Vranovsky A; Ladicka M; Lakota J
Neoplasma; 2008; 55(2):107-12. PubMed ID: 18652043
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of high malignancy lymphoma with intensive short-term chemotherapy using the MACOP-B regimen].
Delmer A; Bauduer F; Ruskoné-Fourmestraux A; Ajchenbaum-Cymbalista F; Delmas-Marsalet B; Rio B; Marie JP; Zittoun R
Bull Cancer; 1993 Sep; 80(9):808-15. PubMed ID: 7515735
[TBL] [Abstract][Full Text] [Related]
5. [Value of MACOP B polychemotherapy for malignant non-Hodgkin's lymphomas in AIDS infected patients].
Taillan B; Ferrari E; Garnier G; Fuzibet JG; Vinti H; Dujardin P
Presse Med; 1992 Feb; 21(6):269. PubMed ID: 1372976
[No Abstract] [Full Text] [Related]
6. Modified MACOP-B chemotherapy for intermediate and high grade non Hodgkins lymphomas.
Gopal R; Nair R; Saikia TK; Soman CS; Dinshaw KA; Advani SH
J Assoc Physicians India; 1994 Oct; 42(10):781-4. PubMed ID: 7533151
[TBL] [Abstract][Full Text] [Related]
7. [ABP therapy in advanced non-Hodgkin's lymphoma resistant to VCP therapy].
Kuraishi Y; Ozeki H; Takasaki N; Mashizu N; Nagamine D; Usui N; Yamazaki H; Nakamura T; Aiba K; Yokoyama K
Rinsho Ketsueki; 1984 Sep; 25(9):1427-32. PubMed ID: 6084069
[No Abstract] [Full Text] [Related]
8. [Treatment of medium and highly malignant non-Hodgkin's lymphoma with combined chemotherapy using methotrexate, adriamycin, cyclophosphamide, vincristine, prednisone and bleomycin (protocol MACOP-B)].
Pittrová H; Koza V; Vozobulová V; Cetkovský P; Skopek P; Jungerová J; Cepelák V
Vnitr Lek; 1989 Dec; 35(12):1177-82. PubMed ID: 2483776
[TBL] [Abstract][Full Text] [Related]
9. [Intraparenchymal non-neoplastic residual masses after treatment of large-cell non-Hodgkin's lymphoma with intensive chemotherapy].
Montalbán C; Arechaga S; Calleja JL; Bellas C; Patier JL; Berenguer A; García Villanueva A; Marcos Robles J
Med Clin (Barc); 1990 Mar; 94(12):461-4. PubMed ID: 1694944
[TBL] [Abstract][Full Text] [Related]
10. Secondary amenorrhea after Hodgkin's lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: a report from the German Hodgkin's Lymphoma Study Group.
Behringer K; Breuer K; Reineke T; May M; Nogova L; Klimm B; Schmitz T; Wildt L; Diehl V; Engert A;
J Clin Oncol; 2005 Oct; 23(30):7555-64. PubMed ID: 16234521
[TBL] [Abstract][Full Text] [Related]
11. Primary non-Hodgkin's lymphoma of the CNS treated with CHOD/BVAM or BVAM chemotherapy before radiotherapy: long-term survival and prognostic factors.
Bessell EM; Graus F; Lopez-Guillermo A; Lewis SA; Villa S; Verger E; Petit J
Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):501-8. PubMed ID: 15145169
[TBL] [Abstract][Full Text] [Related]
12. Long-term follow-up of a prospective study of combined modality therapy for stage I-II indolent non-Hodgkin's lymphoma.
Seymour JF; Pro B; Fuller LM; Manning JT; Hagemeister FB; Romaguera J; Rodriguez MA; Ha CS; Smith TL; Ayala A; Hess M; Cox JD; Cabanillas F; McLaughlin P
J Clin Oncol; 2003 Jun; 21(11):2115-22. PubMed ID: 12775737
[TBL] [Abstract][Full Text] [Related]
13. Essential thrombocythemia after treatment of non-Hodgkin's lymphoma.
Maciel JF; de Lourdes Chauffaille M; Inaoka RJ; Colleoni GW; Yamamoto M
Leuk Res; 2007 Nov; 31(11):1593-5. PubMed ID: 17324461
[No Abstract] [Full Text] [Related]
14. [Clinical characteristics and treatment of midline nasal and nasal type NK/T cell lymphoma].
Yong W; Zheng W; Zhang Y
Zhonghua Yi Xue Za Zhi; 2001 Jul; 81(13):773-5. PubMed ID: 11798962
[TBL] [Abstract][Full Text] [Related]
15. How do patients with aggressive non-Hodgkin's lymphoma treated with third-generation regimens (MACOP-B and F-MACHOP) fare in the long-term?
Zinzani PL; Martelli M; Magagnoli M; Zaja F; Storti S; Pavone E; Lauta VM; De Renzo A; Gobbi M; Bocchia M; Ronconi F; Scaramucci L; Gherlinzoni F; Palombi F; Bendandi M; Stefoni V; Anticoli Borza P; Cellini C; Mandelli F; Tura S
Haematologica; 1999 Nov; 84(11):996-1001. PubMed ID: 10553159
[TBL] [Abstract][Full Text] [Related]
16. A prospective, non-randomised phase 1-2 trial of VACOP-B with filgrastim support for HIV-related non-Hodgkin's lymphoma.
Sawka CA; Shepherd FA; Franssen E; Brandwein J; Dotten DA; Routy JP; Walker IR; St-Louis J; Taylor M; Arts K; Crump M; Foote M
Biotechnol Annu Rev; 2005; 11():381-9. PubMed ID: 16216784
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapy in patients with acquired immunodeficiency virus syndrome associated with non-Hodgkin's lymphoma.
Fridrik MA; Geit M; Wahl G; Ehrengruber A; Simma R; Höpfel I; Bettelheim P; Leisch F
Wien Klin Wochenschr; 1998 Jan; 110(1):15-9. PubMed ID: 9499473
[TBL] [Abstract][Full Text] [Related]
18. Non-Hodgkin's lymphoma associated with the acquired immunodeficiency syndrome.
Cáceres W
Bol Asoc Med P R; 1995; 87(10-12):158-61. PubMed ID: 8924158
[TBL] [Abstract][Full Text] [Related]
19. Stevens-Johnson syndrome associated with methotrexate treatment for non-Hodgkin's lymphoma.
Cuthbert RJ; Craig JI; Ludlam CA
Ulster Med J; 1993 Apr; 62(1):95-7. PubMed ID: 7685956
[No Abstract] [Full Text] [Related]
20. A case of primary rectal non-Hodgkin's lymphoma treated with chemotherapy.
Singla R; Kumar P; Bahl A; Kumar S; Saran RK; Kar P
Trop Gastroenterol; 2008; 29(4):227-8. PubMed ID: 19323094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
